Nu Skin Enterprises (NUS) 10-Q2 Nov 172017 Q3 Quarterly reportFinancial data

Company Profile

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
Document and Entity Information - shares	Sep. 30, 2017	Oct. 31, 2017
Entity Information [Line Items]
Entity Registrant Name	NU SKIN ENTERPRISES INC
Entity Central Index Key	1,021,561
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q3
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2017
Common Class A [Member]
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		52,650,647

Consolidated Balance Sheets (Un

Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Current assets:
Cash and cash equivalents	$ 363,769	$ 357,246
Current investments	7,983	10,880
Accounts receivable	37,725	31,199
Inventories, net	252,470	249,936
Prepaid expenses and other	87,282	65,076
Total current assets	749,229	714,337
Property and equipment, net	449,555	444,732
Goodwill	114,954	114,954
Other intangible assets, net	68,904	63,553
Other assets	164,689	136,469
Total assets	1,547,331	1,474,045
Current liabilities:
Accounts payable	41,638	41,261
Accrued expenses	276,486	275,023
Current portion of long-term debt	101,701	82,727
Total current liabilities	419,825	399,011
Long-term debt	316,519	334,165
Other liabilities	93,464	76,799
Total liabilities	829,808	809,975
Commitments and contingencies (Note 11)
Stockholders' equity:
Class A common stock - 500 million shares authorized, $.001 par value, 90.6 million shares issued	91	91
Additional paid-in capital	460,782	439,635
Treasury stock, at cost - 37.8 million and 38.0 million shares	(1,284,043)	(1,250,123)
Accumulated other comprehensive loss	(69,233)	(84,122)
Retained earnings	1,609,926	1,558,589
Total stockholders' equity	717,523	664,070
Total liabilities and stockholders' equity	$ 1,547,331	$ 1,474,045

Consolidated Balance Sheets (U3

Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares shares in Millions	Sep. 30, 2017	Dec. 31, 2016
Stockholders' equity:
Common stock, shares authorized (in shares)	500	500
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares issued (in shares)	90.6	90.6
Treasury stock (in shares)	37.8	38

Consolidated Statements of Inco

Consolidated Statements of Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Consolidated Statements of Income (Unaudited) [Abstract]
Revenue	$ 563,698	$ 604,162	$ 1,612,898	$ 1,676,468
Cost of sales	120,832	125,863	353,619	391,937
Gross profit	442,866	478,299	1,259,279	1,284,531
Operating expenses:
Selling expenses	235,285	255,274	672,646	699,196
General and administrative expenses	143,219	140,651	411,270	415,014
Total operating expenses	378,504	395,925	1,083,916	1,114,210
Operating income	64,362	82,374	175,363	170,321
Other income (expense), net	(1,172)	(5,695)	(8,470)	(19,618)
Income before provision for income taxes	63,190	76,679	166,893	150,703
Provision for income taxes	21,518	19,807	55,691	45,802
Net income	$ 41,672	$ 56,872	$ 111,202	$ 104,901
Net income per share (Note 2):
Basic (in dollars per share)	$ 0.79	$ 1.02	$ 2.10	$ 1.87
Diluted (in dollars per share)	$ 0.76	$ 0.98	$ 2.04	$ 1.85
Weighted-average common shares outstanding:
Basic (in shares)	52,873	55,983	52,834	55,963
Diluted (in shares)	54,834	57,852	54,519	56,586

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Consolidated Statements of Comprehensive Income (Unaudited) [Abstract]
Net income	$ 41,672	$ 56,872	$ 111,202	$ 104,901
Other comprehensive income, net of tax:
Foreign currency translation adjustment, net of taxes of $(3,054) and $(760) for the three months ended September 30, 2017 and 2016, respectively, and $(1,376) and $(2,324) for the nine months ended September 30, 2017 and 2016, respectively	5,497	2,463	15,273	4,413
Net unrealized gains/(losses) on foreign currency cash flow hedges, net of taxes of $15 and $147 for the three months ended September 30, 2017 and 2016, respectively, and $114 and $1,722 for the nine months ended September 30, 2017 and 2016, respectively	(27)	(266)	(207)	(3,126)
Reclassification adjustment for realized losses/(gains) in current earnings, net of taxes of $(22) and $(409) for the three months ended September 30, 2017 and 2016, respectively, and $97 and $(803) for the nine months ended September 30, 2017 and 2016, respectively	40	743	(177)	1,459
Total other comprehensive income	5,510	2,940	14,889	2,746
Comprehensive income	$ 47,182	$ 59,812	$ 126,091	$ 107,647

Consolidated Statements of Com6

Consolidated Statements of Comprehensive Income (Unaudited) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Other comprehensive income, net of tax:
Foreign currency translation adjustment, tax	$ (3,054)	$ (760)	$ (1,376)	$ (2,324)
Net unrealized gains/(losses) on foreign currency cash flow hedges, tax	15	147	114	1,722
Reclassification adjustment for realized losses/(gains) in current earnings, tax	$ (22)	$ (409)	$ 97	$ (803)

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Cash flows from operating activities:
Net income	$ 111,202	$ 104,901
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	52,525	53,402
Equity method earnings	(655)	0
Japan customs expense	0	31,355
Foreign currency losses	(2,381)	14,749
Stock-based compensation	14,493	5,163
Deferred taxes	6,711	(5,718)
Changes in operating assets and liabilities:
Accounts receivable	(5,115)	671
Inventories, net	5,039	14,957
Prepaid expenses and other	(16,455)	(59,230)
Other assets	(3,960)	(3,842)
Accounts payable	(906)	10,927
Accrued expenses	(9,701)	19,635
Other liabilities	5,009	(1,540)
Net cash provided by operating activities	155,806	185,430
Cash flows from investing activities:
Purchases of property and equipment	(38,965)	(35,019)
Proceeds of investment sales	11,269	14,591
Purchases of investments	(8,244)	(17,024)
Acquisitions and investment in equity investee	(31,745)	(4,400)
Net cash used in investing activities	(67,685)	(41,852)
Cash flows from financing activities:
Exercises of employee stock options	16,377	6,295
Payment of cash dividends	(57,065)	(59,585)
Payments on long-term debt	(72,260)	(50,452)
Proceeds from long-term debt	67,000	233,721
Payment of debt issuance costs	0	(6,596)
Income tax benefit of options exercised	0	4,186
Repurchases of shares of common stock	(47,835)	(41,693)
Net cash provided by (used in) financing activities	(93,783)	85,876
Effect of exchange rate changes on cash	12,185	(1,814)
Net increase in cash and cash equivalents	6,523	227,640
Cash and cash equivalents, beginning of period	357,246	289,354
Cash and cash equivalents, end of period	$ 363,769	$ 516,994

THE COMPANY

THE COMPANY	9 Months Ended
THE COMPANY	Sep. 30, 2017
THE COMPANY [Abstract]
THE COMPANY	1. Nu Skin Enterprises, Inc. (the "Company") is a leading, global direct selling company that develops and distributes premium-quality, innovative personal care products and nutritional supplements that are sold worldwide under the Nu Skin and Pharmanex brands and a small number of other products and services. Over the last several years, the Company has introduced new Pharmanex nutritional supplements and Nu Skin personal care products under its ageLOC

NET INCOME PER SHARE

NET INCOME PER SHARE	9 Months Ended
NET INCOME PER SHARE	Sep. 30, 2017
NET INCOME PER SHARE [Abstract]
NET INCOME PER SHARE	2. NET INCOME PER SHARE Net income per share is computed based on the weighted-average number of common shares outstanding during the periods presented. Additionally, diluted earnings per share data gives effect to all potentially dilutive common shares that were outstanding during the periods presented. For the three-month periods ended September 30, 2017 and 2016, stock options of 0.2 million and 0.2 million, respectively, and for the nine-month periods ended September 30, 2017 and 2016, stock options of 0.4 million and 1.2 million, respectively, were excluded from the calculation of diluted earnings per share because they were anti-dilutive.

DIVIDENDS PER SHARE

DIVIDENDS PER SHARE	9 Months Ended
DIVIDENDS PER SHARE	Sep. 30, 2017
DIVIDENDS PER SHARE [Abstract]
DIVIDENDS PER SHARE	3. DIVIDENDS PER SHARE In February, May and August 2017, the Company's board of directors declared a quarterly cash dividend of $0.36 per share. These quarterly cash dividends of $19.0 million, $19.1 million and $19.0 million were paid on March 15, 2017, June 14, 2017 and September 13, 2017 to stockholders of record on February 27, 2017, May 26, 2017 and August 25, 2017. In October 2017, the Company's board of directors declared a quarterly cash dividend of $0.36 per share to be paid on December 6, 2017 to stockholders of record on November 17, 2017.

DERIVATIVE FINANCIAL INSTRUMENT

DERIVATIVE FINANCIAL INSTRUMENTS	9 Months Ended
DERIVATIVE FINANCIAL INSTRUMENTS	Sep. 30, 2017
DERIVATIVE FINANCIAL INSTRUMENTS [Abstract]
DERIVATIVE FINANCIAL INSTRUMENTS	4. DERIVATIVE FINANCIAL INSTRUMENTS The Company enters into non-designated foreign currency derivatives, primarily comprised of foreign currency forward contracts, for which hedge accounting does not apply. The changes in the fair market value of these non-designated derivatives are included in other income/expense in the Company's consolidated statements of income. The Company uses non-designated foreign currency derivatives to hedge foreign-currency-denominated intercompany transactions and to partially mitigate the impact of foreign-currency fluctuations. The fair value of the non-designated foreign currency derivatives is based on third-party quotes. As of September 30, 2017, the Company did not hold any non-designated derivative contracts. As of September 30, 2016, the Company held non-designated derivative contracts with notional amounts of 300 million Japanese yen ($3.0 million), 11.5 billion South Korean won ($10.4 million). Gains and losses related to non-designated derivative contracts are recorded as part of Other Income (Expense). The following table summarizes gains (losses) related to derivative instruments not designated as hedging instruments during the three- and nine-month periods ended September 30, 2017 and 2016 (U.S. dollars in thousands): Derivatives not designated as hedging instruments: Location of Gain (Loss) Recognized in Income Amount of Gain (Loss) Recognized in Income Three Months Ended Nine Months Ended September 30, September 30, 2017 2016 2017 2016 Foreign currency contracts Other income (expense) $ — $ (765) $ (485) $ (1,243) The Company designates as cash-flow hedges those foreign currency forward contracts it enters to hedge forecasted intercompany transactions that are subject to foreign currency exposures. Changes in the fair value of these forward contracts designated as cash-flow hedges are recorded as a component of accumulated other comprehensive income (loss) within shareholders' equity (deficit), and are recognized in the consolidated statement of income during the period which approximates the time the hedged transaction is settled. As of September 30, 2017, the Company held forward contracts designated as foreign currency cash flow hedges with notional amounts totaling 1.4 billion Japanese yen ($12.4 million) and 2.3 billion Japanese yen and 6.0 million euros ($22.7 million and $6.7 million, respectively) as of September 30, 2016 to hedge forecasted foreign-currency-denominated intercompany transactions. The fair value of these hedges were $0.3 million and ($2.1 million) as of September 30, 2017 and 2016, respectively. The contracts held at September 30, 2017 have maturities through June 2018, and accordingly, all unrealized gains and losses on foreign currency cash flow hedges included in accumulated other comprehensive loss will be recognized in current earnings over the next 9 months. The following table summarizes gains (losses) related to derivative instruments recorded in other comprehensive income (loss) during the three- and nine-month periods ended September 30, 2017 and 2016 (U.S. dollars in thousands): Amount of Gain (Loss) Recognized in Other Comprehensive Loss Three Months Ended Nine Months Ended September 30, September 30, Derivatives designated as hedging instruments: 2017 2016 2017 2016 Foreign currency forward contracts related to intercompany license fee, product sales, and selling expense hedges $ (27) $ (266) $ (207) $ (3,126) The following table summarizes gains (losses) relating to derivative instruments reclassified from accumulated other comprehensive loss into income during the three- and nine-month periods ended September 30, 2017 and 2016 (U.S. dollars in thousands): Derivatives designated as hedging instruments: Location of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income Three Months Ended Nine Months Ended September 30, September 30, 2017 2016 2017 2016 Foreign currency forward contracts related to intercompany license fees and product sales hedges Revenue $ (67) $ (300) $ 42 $ (609) Foreign currency forward contracts related to intercompany selling expense hedges Selling expenses $ 5 $ (443) $ 233 $ (850) As of September 30, 2017 and December 31, 2016, there were $0.2 million and $0.6 million, respectively, of unrealized gains/(losses) included in accumulated other comprehensive loss related to foreign currency cash flow hedges. The remaining $69.4 million and $84.7 million as of September 30, 2017 and December 31, 2016, respectively, in accumulated other comprehensive loss are related to cumulative translation adjustments. The Company assesses hedge effectiveness at least quarterly. During the three and nine months ended September 30, 2017 and 2016, all hedges were determined to be effective. The Company reports its derivatives at fair value as either other current assets or accrued expenses within its consolidated balance sheet. See Note 13 Fair Value.

REPURCHASES OF COMMON STOCK

REPURCHASES OF COMMON STOCK	9 Months Ended
REPURCHASES OF COMMON STOCK	Sep. 30, 2017
REPURCHASES OF COMMON STOCK [Abstract]
REPURCHASES OF COMMON STOCK	5. REPURCHASES OF COMMON STOCK During the three-month periods ended September 30, 2017 and 2016, the Company repurchased 0.4 million and 0.3 million shares of its Class A common stock under its open-market stock repurchase plan for $25.7 million and $17.4 million, respectively. During the nine-month periods ended September 30, 2017 and 2016, the Company repurchased 0.8 million and 1.0 million shares of its Class A common stock under its open market repurchase plan for $47.8 million and $41.7 million, respectively. As of September 30, 2017, $151.9 million was available for repurchases under the Company's open market stock repurchase plan.

SEGMENT INFORMATION

SEGMENT INFORMATION	9 Months Ended
SEGMENT INFORMATION	Sep. 30, 2017
SEGMENT INFORMATION [Abstract]
SEGMENT INFORMATION	6. SEGMENT INFORMATION As a result of the Company's management changes in the first quarter of 2017, the Company concluded that the Chief Operating Decision Maker, as defined in ASC 280, is now comprised of the CEO, President and CFO. This change required the Company to reevaluate its determination of operating segments. The Company's operating segments are based on geographic regions that generate revenue and hold its long-lived assets. The Company sells and distributes its products through a global network of customers and sales leaders in approximately 50 markets. The Company has divided these markets into seven operating segments, which are the Company's reportable segments: Mainland China, Hong Kong/Taiwan, South Korea, Japan, South Asia/Pacific, Americas and EMEA. The seven reportable segments generate revenue from the sale of personal care products and nutritional supplements under the Nu Skin and Pharmanex brands, have similar business characteristics and align with how the CODM function began assessing performance and allocating resources in the first quarter of 2017. Profitability by segment as reported under US GAAP is driven primarily by the Company's international taxation policies. Segment contribution, which is the Company's segment profitability metric presented in the table below, excludes certain intercompany charges, specifically royalties, license fees, transfer pricing, discrete charges and other miscellaneous items. These charges have been included in Corporate and other expenses. Corporate and other expenses also include costs related to the Company's executive and administrative offices, information technology, research and development, marketing and supply chain functions not recorded at the segment level. The accounting policies of the segments are the same as those described in Note 1 – The Company. The Company evaluates the performance of its segments based on revenue and segment contribution. Each segment records direct expenses related to its employees and its operations. Summarized financial information for the Company's reportable segments is shown in the following tables. Asset information is not reviewed or included with the Company's internal management reporting. Therefore, the Company has not disclosed asset information for each reportable segment. Revenue by Segment Three Months Ended September 30, Nine Months Ended September 30, (U.S. dollars in thousands) 2017 2016 2017 2016 Mainland China $ 172,556 $ 168,320 $ 494,658 $ 471,319 South Korea 89,238 136,188 258,626 315,342 Americas 79,214 71,250 221,968 204,882 South Asia/Pacific 78,994 70,867 216,727 226,742 Japan 62,513 72,489 188,465 210,429 Hong Kong/Taiwan 41,050 48,140 120,069 140,568 EMEA 40,133 36,908 112,385 107,186 Total $ 563,698 $ 604,162 $ 1,612,898 $ 1,676,468 Segment Contribution Three Months Ended September 30, Nine Months Ended September 30, (U.S. dollars in thousands) 2017 2016 2017 2016 Mainland China $ 42,375 $ 38,240 $ 130,085 $ 113,250 South Korea 23,713 41,739 70,503 89,991 Americas 12,822 11,637 34,564 34,286 South Asia/Pacific 18,664 16,371 47,083 53,172 Japan 12,786 15,510 36,134 43,490 Hong Kong/Taiwan 8,096 10,401 20,945 25,829 EMEA 2,896 3,258 8,304 6,438 Total segment contribution 121,352 137,156 347,618 366,456 Corporate and other (56,990 ) (54,782 ) (172,255 ) (196,135 ) Operating income 64,362 82,374 175,363 170,321 Other income (expense) (1,172 ) (5,695 ) (8,470 ) (19,618 ) Income before provision for income taxes $ 63,190 $ 76,679 $ 166,893 $ 150,703 Depreciation and Amortization Three Months Ended September 30, Nine Months Ended September 30, (U.S. dollars in thousands) 2017 2016 2017 2016 Mainland China $ 3,550 $ 4,218 $ 11,202 $ 12,362 South Korea 1,586 1,773 4,872 5,137 Americas 341 672 1,319 2,010 South Asia/Pacific 585 636 1,733 1,796 Japan 898 1,002 2,677 2,848 Hong Kong/Taiwan 353 558 999 1,669 EMEA 226 356 820 1,027 Corporate and other 9,906 9,503 28,903 26,553 Total $ 17,445 $ 18,718 $ 52,525 $ 53,402 Capital Expenditures Three Months Ended September 30, Nine Months Ended September 30, (U.S. dollars in thousands) 2017 2016 2017 2016 Mainland China $ 688 $ 1,711 $ 2,351 $ 8,709 South Korea — 141 464 520 Americas 133 96 697 585 South Asia/Pacific 284 235 814 1,978 Japan 109 49 206 916 Hong Kong/Taiwan 2 179 1,119 444 EMEA 571 131 882 798 Corporate and other 9,427 7,763 32,432 21,069 Total $ 11,214 $ 10,305 $ 38,965 $ 35,019 Revenue by Major Market A major market is defined as one with total revenue greater than 10% of consolidated total revenue. Based on this criteria, the Company has identified three major markets: Mainland China, South Korea and Japan. There are approximately 50 other markets, each of which individually is less than 10%. No single customer accounted for 10% or more of net sales for the periods presented. Sales are recorded in the jurisdiction in which the transactions occurred (U.S. dollars in thousands): Revenue by Product Line Three Months Ended Nine Months Ended September 30, September 30, 2017 2016 2017 2016 Nu Skin $ 338,305 $ 343,131 $ 985,465 $ 998,386 Pharmanex 224,031 259,896 623,046 674,624 Other 1,362 1,135 4,387 3,458 Totals $ 563,698 $ 604,162 $ 1,612,898 $ 1,676,468 Long-Lived Assets by Major Market A major market is defined as a market with long-lived assets greater than 10% of consolidated long-lived assets and also includes the Company's country of domicile (the U.S.). Long-lived assets in Mainland China consist primarily of property, plant and equipment related to manufacturing, distribution facilities and the Mainland China headquarters. Long-lived assets in the U.S. consist primarily of property, plant and equipment, including the Company's corporate offices and distribution facilities. Long-lived assets by major markets are set forth below for the periods ended September 30, 2017 and December 31, 2016 (U.S. dollars in thousands): September 30, 2017 December 31, 2016 United States $ 294,567 $ 283,868 Mainland China 93,108 97,867 South Korea 40,446 41,545 Japan 9,447 11,517 All others 11,987 9,935 Total $ 449,555 $ 444,732

GOODWILL

GOODWILL	9 Months Ended
GOODWILL	Sep. 30, 2017
GOODWILL [Abstract]
GOODWILL	7. GOODWILL During the first quarter of 2017, the Company realigned its operational segments and reporting structure to reflect how the business will be managed going forward. As part of this realignment, the Company divided its single operating segment into seven geographical reporting segments. The Company's reporting units for goodwill are its operating segments, which are also its reportable segments. As a result of the segment changes, the historical goodwill of $115.0 million was allocated to the seven reportable segments. The following table presents goodwill allocated to the Company's reportable segments for the periods ended September 30, 2017 and December 31, 2016 (U.S. dollars in thousands): September 30, 2017 December 31, 2016 (1) Mainland China $ 32,179 $ 32,179 South Korea 29,261 29,261 Americas 9,449 9,449 South Asia/Pacific 18,537 18,537 Japan 16,019 16,019 Hong Kong/Taiwan 6,634 6,634 EMEA 2,875 2,875 Total $ 114,954 $ 114,954 (1) Goodwill was recast to reflect current period presentation by geographic region at December 31, 2016.

INVENTORY

INVENTORY	9 Months Ended
INVENTORY	Sep. 30, 2017
INVENTORY [Abstract]
INVENTORY	8. INVENTORY Inventories consist of the following (U.S. dollars in thousands): September 30, 2017 December 31, 2016 Raw materials $ 95,339 $ 108,276 Finished goods 157,131 141,660 $ 252,470 $ 249,936

DEFERRED TAX ASSETS AND LIABILI

DEFERRED TAX ASSETS AND LIABILITIES	9 Months Ended
DEFERRED TAX ASSETS AND LIABILITIES	Sep. 30, 2017
DEFERRED TAX ASSETS AND LIABILITIES [Abstract]
DEFERRED TAX ASSETS AND LIABILITIES	9. DEFERRED TAX ASSETS AND LIABILITIES The Company accounts for income taxes in accordance with the Income Taxes Topic of the Financial Accounting Standards Codification. These standards establish financial accounting and reporting standards for the effects of income taxes that result from an enterprise's activities during the current and preceding years. The Company takes an asset and liability approach for financial accounting and reporting of income taxes. The Company pays income taxes in many foreign jurisdictions based on the profits realized in those jurisdictions, which can be significantly impacted by terms of intercompany transactions between the Company and its foreign affiliates. Deferred tax assets and liabilities are created in this process. The Company has netted these deferred tax assets and deferred tax liabilities by jurisdiction. Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be ultimately realized. As of September 30, 2017 and December 31, 2016, the Company had net deferred tax assets of $29.3 million and $35.1 million, respectively. The Company evaluates its indefinite reinvestment assertions with respect to foreign earnings for each quarter. Other than earnings the Company intends to reinvest indefinitely, the Company accrues for the U.S. federal and state income taxes applicable to the earnings. For all foreign earnings, the Company accrues the applicable foreign income taxes. The Company intends to utilize the offshore earnings to fund foreign investments, specifically capital expenditures. Undistributed earnings that the Company has indefinitely reinvested, for which no federal or state income taxes in the U.S. have been provided, aggregate to $70.0 million as of December 31, 2016. If the amount designated as indefinitely reinvested as of December 31, 2016 was repatriated to the United States, the amount of incremental taxes would be approximately $7.6 million.

UNCERTAIN TAX POSITIONS

UNCERTAIN TAX POSITIONS	9 Months Ended
UNCERTAIN TAX POSITIONS	Sep. 30, 2017
UNCERTAIN TAX POSITIONS [Abstract]
UNCERTAIN TAX POSITIONS	10. UNCERTAIN TAX POSITIONS The Company files income tax returns in the U.S. federal jurisdiction, and in various state and foreign jurisdictions. The Company is no longer subject to tax examinations from the IRS for all years for which tax returns have been filed before 2011. With a few exceptions, the Company is no longer subject to state and local income tax examination by tax authorities for the years before 2011. In 2009, the Company entered into a voluntary program with the IRS called Compliance Assurance Process ("CAP"). The objective of CAP is to contemporaneously work with the IRS to achieve federal tax compliance and resolve all or most of the issues prior to filing of the tax return. The Company has elected to participate in the CAP program for 2017 and may elect to continue participating in CAP for future tax years; the Company may withdraw from the program at any time. In major foreign jurisdictions, the Company is generally no longer subject to income tax examinations for years before 2010. However, statutes in certain countries may be as long as ten years for transfer pricing related issues. Along with the IRS examination of 2011, the Company is currently under examination in certain foreign jurisdictions; however, the outcomes of those reviews are not yet determinable. The Company's unrecognized tax benefits relate to multiple foreign and domestic jurisdictions. There are potential changes in unrecognized tax benefits from the multiple jurisdictions in which the Company operates, as well as the expiration of various statutes of limitation and possible completion of tax examinations; however, the Company does not anticipate that total unrecognized tax benefits will significantly change over the next 12 months.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	9 Months Ended
COMMITMENTS AND CONTINGENCIES	Sep. 30, 2017
COMMITMENTS AND CONTINGENCIES [Abstract]
COMMITMENTS AND CONTINGENCIES	11. COMMITMENTS AND CONTINGENCIES The Company is subject to government regulations pertaining to product formulation, labeling and packaging, product claims and advertising, and the Company's direct selling system. The Company is also subject to the jurisdiction of numerous foreign tax and customs authorities. Any assertions or determination that either the Company or the Company's sales force is not in compliance with existing statutes, laws, rules or regulations could have a material adverse effect on the Company's operations. In addition, in any country or jurisdiction, the adoption of new statutes, laws, rules or regulations or changes in the interpretation of existing statutes, laws, rules or regulations could have a material adverse effect on the Company and its operations. No assurance can be given that the Company's compliance with applicable statutes, laws, rules and regulations will not be challenged by foreign authorities or that such challenges will not have a material adverse effect on the Company's financial position, results of operations or cash flows. The Company and its Subsidiaries are defendants in litigation, investigations and other proceedings involving various matters. In the opinion of the Company's management, based upon advice of its counsel handling such litigation, investigations and other proceedings, adverse outcomes, if any, will not likely result in a material effect on the Company's consolidated financial condition, results of operations or cash flows. The Company is subject to regular audits by federal, state and foreign tax authorities. These audits may result in additional tax liabilities. The Company believes it has appropriately provided for income taxes for all years. Several factors drive the calculation of its tax reserves. Some of these factors include: (i) the expiration of various statutes of limitations; (ii) changes in tax law and regulations; (iii) issuance of tax rulings; and (iv) settlements with tax authorities. Changes in any of these factors may result in adjustments to the Company's reserves, which would impact its reported financial results.

DEBT

DEBT	9 Months Ended
DEBT	Sep. 30, 2017
DEBT [Abstract]
DEBT	12. DEBT Credit Agreement On October 9, 2014, the Company entered into a Credit Agreement (the "Credit Agreement") with various financial institutions, and Bank of America, N.A. as administrative agent. The Credit Agreement provides for a $127.5 million term loan facility, a 6.6 billion Japanese yen term loan facility and a $187.5 million revolving credit facility, each with a term of five years. On October 10, 2014, the Company drew the full amount of the term loan facilities, and as of September 30, 2017 and December 31, 2016, the Company had an outstanding balance of $72.5 million and $47.5 million, respectively, on the revolving credit facility. Any additional amounts drawn under the revolving credit facility will bear interest at rates that will be determined in accordance with the Credit Agreement. The Credit Agreement requires that the Company maintains a consolidated leverage ratio not exceeding 2.25 to 1.00 and a consolidated interest coverage ratio of no less than 3.00 to 1.00. The Company believes these covenants provide it with greater flexibility to pay dividends and repurchase stock. The Company is in compliance with its debt covenants. Convertible Note On June 16, 2016, the Company issued $210.0 million of convertible senior notes (the "Convertible Notes") in a private offering to a Chinese investor (the "Holder"). The Convertible Notes are senior unsecured obligations which will rank equal in right of payment to all senior unsecured indebtedness of the Company and will rank senior in right of payment to any indebtedness that is contractually subordinated to the Convertible Notes. Interest on the Convertible Notes is payable semiannually in arrears on June 15 and December 15 of each year at a rate of 4.75% per annum. The Convertible Notes mature on June 15, 2020, unless repurchased or converted prior to maturity. Prior to the stated maturity date, the Company may, at its option, redeem all or part of the Convertible Notes at a price equal to 100% of the principal amount thereof, plus accrued and unpaid interest, if any, provided that its common stock share price is equal to or exceeds 180% of the applicable conversion price for 20 or more trading days (including the final three trading days) in the 30 consecutive trading days prior to the Company's exercise of such redemption right. The Holder of the Convertible Notes may, at its option, cause the Company to repurchase all of such Holder's Convertible Notes or any portion thereof that is equal to $1,000 in principal amount or multiples of $1,000 upon a change in control or a termination of trading of the Company's common stock, as those terms are defined in the indenture governing the Convertible Notes. In addition, each holder of the Convertible Notes shall have the right, at such holder's option, to convert all or any portion thereof that is equal to $1,000 in principal amount or multiples of $1,000 at any time beginning six calendar months following June 16, 2016, at the then-applicable conversion rate. Upon conversion by the Holder, the Convertible Notes will be settled in cash with respect to principal and any accrued and unpaid interest to such date and in the Company's common shares with respect to any additional amounts, based on the applicable conversion rate at such time. The Convertible Notes had an initial conversion rate of 21.5054 common shares per $1,000 principal amount of the Convertible Notes (which is equal to an initial conversion price of approximately $46.50 per common share). Throughout the term of the Convertible Notes, the conversion rate may be adjusted upon the occurrence of certain specified events. Of the $210.0 million in proceeds received from the issuance of the Convertible Notes, $199.1 million was allocated to long-term debt (the "Liability Component") and $10.9 million was allocated to additional paid-in capital (the "Equity Component") within the Company's consolidated balance sheet. The Liability Component was calculated by measuring the fair value of a similar debt instrument that does not have an associated conversion feature. The amount allocated to the Equity Component, which represents the conversion option, was calculated by deducting the fair value of the Liability Component from the par value of the Convertible Notes. The Company determined that the conversion option does not require separate accounting treatment as a derivative instrument because it is both indexed to the Company's own stock and would be classified in stockholders' equity if freestanding. The Equity Component will not be remeasured as long as it continues to meet the conditions for equity classification. The excess of the principal amount of the Liability Component over its carrying amount (the "Debt Discount") will be amortized to interest expense over the term of the Convertible Notes. As a result, the Liability Component will be accreted up to the Convertible Notes' $210.0 million face value, resulting in additional non-cash interest expense being recognized within the Company's consolidated statement of income. The effective interest rate on the Convertible Notes is approximately 7.1% per annum. The net carrying amount of the Liability Component is as follows (U.S. dollars in thousands): September 30, 2017 Principal $ 210,000 Unamortized debt discount (conversion option) (7,731 ) Total long-term debt, net 202,269 Unamortized debt discount (issuance costs) (4,424 ) Net carrying amount $ 197,845 The net carrying amount of the Liability Component was recorded to long-term debt within the Company's consolidated balance sheet. The Company incurred approximately $6.6 million of issuance costs related to the issuance of the Convertible Notes. Of the $6.6 million in issuance costs incurred, $6.3 million and $0.3 million were recorded to deferred financing cost and additional paid-in capital, respectively, in proportion to the allocation of the proceeds of the Convertible Notes. The $6.3 million recorded to deferred financing cost on the Company's consolidated balance sheet as a reduction of long-term debt is being amortized over the contractual term of the Convertible Notes using the effective interest method. During the three months ended September 30, 2017, the Company recognized $3.5 million in interest expense related to the Convertible Notes, which included $2.5 million of contractual interest and $1.0 million in amortization of debt issuance costs and in amortization of the Debt Discount. The following table summarizes the Company’s debt facilities as of September 30, 2017 and December 31, 2016: Facility or Arrangement Original Principal Amount Balance as of September 30, 2017 (1)(2) Balance as of December 31, 2016 Interest Rate Repayment terms Credit Agreement term loan facility: U.S. dollar denominated: $127.5 million $98.8 million $108.4 million Variable 30 day: 3.98% One half of the principal amount payable in increasing quarterly installments over a five-year period beginning on December 31, 2014, with the remainder payable at the end of the five-year term. Japanese yen denominated: 6.6 billion yen 5.1 billion yen ($45.4 million as of September 30, 2017) 5.6 billion yen ($47.9 million as of December 31, 2016) Variable 30 day: 2.75% One half of the principal amount payable in increasing quarterly installments over a five-year period beginning on December 31, 2014, with the remainder payable at the end of the five-year term. Credit Agreement revolving credit facility: $72.5 million $47.5 million Variable 30 day: 3.98% Revolving line of credit expires October 2019. Korea subsidiary loan: $20.0 million — $10.0 million 1.12% Loan paid in full as of March 2017. Japan subsidiary loan: 2.0 billion yen 0.7 billion yen ($5.9 million as of September 30, 2017) 1.3 billion yen ($11.4 million as of December 31, 2016) 0.66% Payable in semi-annual installments over three years that began on January 31, 2016. Convertible note: $210.0 million $210.0 million $210.0 million 4.75% Principal amount payable on June 15, 2020. (1) As of September 30, 2017, the current portion of the Company's debt (i.e. becoming due in the next 12 months) included $16.0 million of the balance of its U.S. dollar denominated debt under the Credit Agreement facility, $7.3 million of the balance of its Japanese yen-denominated debt under the Credit Agreement facility and $5.9 million of the Japan subsidiary loan. The Company has classified the $72.5 million borrowed under the revolving line of credit as short term because it is the Company's intention to use the line of credit to borrow and pay back funds over short periods of time. (2) The carrying value of the debt reflects the amounts stated in the above table less a debt discount of $10.0 million and debt issuance costs of $4.4 million (consisting of $12.1 million related to the Convertible Note and $2.3 million related to the credit agreement), which is not reflected in this table.

FAIR VALUE

FAIR VALUE	9 Months Ended
FAIR VALUE	Sep. 30, 2017
FAIR VALUE [Abstract]
FAIR VALUE	13. FAIR VALUE The carrying value of financial instruments including cash and cash equivalents, accounts receivable and accounts payable approximate fair values due to the short-term nature of these instruments. The Company's current investments as of September 30, 2017 include certificates of deposits and pre-refunded municipal bonds that are classified by management as held-to-maturity as the Company had the positive intent and ability to hold to maturity. The carrying value of these current investments approximate fair values due to the short-term nature of these instruments. The Company has classified these instruments as Level 2 in the fair value hierarchy. Fair value estimates are made at a specific point in time, based on relevant market information. The FASB Codification defines fair value as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. On a quarterly basis, the Company measures at fair value certain financial assets, including cash equivalents. Accounting standards specify a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect data obtained from independent sources, while unobservable inputs reflect the Company's market assumptions. These two types of inputs have created the following fair-value hierarchy: ▪ Level 1 – quoted prices in active markets for identical assets or liabilities; ▪ Level 2 – inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; ▪ Level 3 – unobservable inputs based on the Company's own assumptions. Accounting standards permit companies, at their option, to measure certain financial instruments and other eligible items at fair value. The Company has elected not to apply the fair value option to existing eligible items beyond what is required by US GAAP. The following tables present the fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis (U.S. dollars in thousands): Fair Value at September 30, 2017 Level 1 Level 2 Level 3 Total Financial assets (liabilities): Cash equivalents and current investments $ 40,070 $ — $ — $ 40,070 Other long-term assets 3,472 — — 3,472 Forward contracts — 275 — 275 Life insurance contracts — — 36,747 36,747 Total $ 43,542 $ 275 $ 36,747 $ 80,564 Fair Value at December 31, 2016 Level 1 Level 2 Level 3 Total Financial assets (liabilities): Cash equivalents and current investments $ 50,307 $ — $ — $ 50,307 Other long-term assets 2,782 — — 2,782 Forward contracts — 1,371 — 1,371 Life insurance contracts — — 32,286 32,286 Total $ 53,089 $ 1,371 $ 32,286 $ 86,746 The following table provides a summary of changes in fair value of the Company's Level 3 marketable securities (U.S. dollars in thousands): Life Insurance Contracts Beginning balance at January 1, 2017 $ 32,286 Actual return on plan assets: Relating to assets still held at the reporting date 3,835 Purchases and issuances 895 Sales and settlements (269 ) Transfers into Level 3 — Ending balance at September 30, 2017 $ 36,747

ACCOUNTING PRONOUNCEMENTS

ACCOUNTING PRONOUNCEMENTS	9 Months Ended
ACCOUNTING PRONOUNCEMENTS	Sep. 30, 2017
ACCOUNTING PRONOUNCEMENTS [Abstract]
ACCOUNTING PRONOUNCEMENTS	14. ACCOUNTING PRONOUNCEMENTS In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606) In July 2015, the FASB issued ASU 2015-11, Inventory (Topic 330): Simplifying the Measurement of Inventory In February 2016, the FASB issued ASU 2016-02, Leases (Subtopic 842) In March 2016, the FASB issued ASU 2016-09, Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting . The objective of this update was to simplify several aspects of the accounting for employee share-based payment transactions, including accounting for income taxes related to share-based compensation, the related classification in the statement of cash-flows, and accounting for share award forfeitures. This ASU was effective for the Company beginning on January 1, 2017 As permitted, the Company elected to classify excess tax benefits as an operating activity in the Statement of Cash Flows instead of as a financing activity on a prospective basis and did not retroactively adjust prior periods. As also permitted by the new guidance, beginning January 1, 2017 the Company has elected to account for share award forfeitures as they occur. Previously, share-based compensation expense was recorded net of estimated forfeitures. A cumulative adjustment of $2.8 million was recorded to retained earnings and additional paid-in capital as of January 1, 2017. Prior periods were not retroactively adjusted. In the second half of 2016, the FASB issued ASU Nos. 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments Statement of Cash Flows (Topic 230): Restricted Cash. In January 2017, the FASB issued ASU 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a In January 2017, the FASB issued ASU 2017-04, Intangibles – Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment . This guidance simplifies the required test of goodwill for impairment by eliminating Step 2 from the goodwill impairment test. If a company determines in Step 1 of the goodwill impairment test that the carrying value of goodwill is less than the fair value, an impairment in that amount should be recorded to the income statement, rather than proceeding to Step 2. This ASU is effective for interim and annual impairment tests in fiscal years beginning after December 15, 2019. Early adoption is permitted. The adoption of this guidance is not expected to have a material impact on the Company's consolidated financial statements. In December 2017, the FASB issued ASU No. 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities The

COST OF SALES

COST OF SALES	9 Months Ended
COST OF SALES	Sep. 30, 2017
COST OF SALES [Abstract]
COST OF SALES	15. COST OF SALES In April 2017, the Tokyo High Court issued a ruling on a dispute between the Company and the customs authorities in Japan. The High Court affirmed the Tokyo District Court’s February 2016 decision upholding previous customs assessments related to the importation of several of the Company’s products into Japan during 2010. The Company filed an appeal with the Japan Supreme Court in May 2017. The High Court’s April 2017 ruling applied only to imports that occurred during 2010, but in September 2017, the Tokyo High Court issued its ruling regarding imports that occurred in 2006-2009 and 2011, which are the other time periods in the dispute. For both of these time periods, the High Court affirmed the Tokyo District Court's decisions upholding previous customs assessments. In October 2017, the Company filed an appeal with the Japan Supreme Court regarding the Tokyo High Court’s September 2017 ruling. As previously disclosed, the Company already recorded a charge of $31.4 million to cost of sales in the first quarter of 2016, when the District Court issued its decision. This charge represents the full amount being disputed. It was a non-cash item because the Company was previously required to pay the assessments.

ACQUISITION AND INVESTMENT IN E

ACQUISITION AND INVESTMENT IN EQUITY INVESTEE	9 Months Ended
ACQUISITION AND INVESTMENT IN EQUITY INVESTEE	Sep. 30, 2017
ACQUISITION AND INVESTMENT IN EQUITY INVESTEE [Abstract]
ACQUISITION AND INVESTMENT IN EQUITY INVESTEE	16. ACQUISITION AND INVESTMENT IN EQUITY INVESTEE Vertical Eden, LLC In the first quarter of 2016, the Company purchased 70% of Vertical Eden, LLC, an early-stage company in the warehouse growing market, based in Alpine, Utah, for $3.3 million in cash and contingent consideration valued at $1.5 million which resulted in $2.5 million of goodwill. In the second quarter of 2017, the Company purchased the remaining 30% of Vertical Eden for $12.5 million in cash. The purchase of Vertical Eden includes specialized technology in remote programming and management of the entire crop growing cycle. As a result of this acquisition, the Company recorded approximately $4.4 million of intangible assets which are being amortized over the useful lives of 3 to 7 years. Treviso, LLC On February 28, 2017, the Company purchased a 35% membership interest in Treviso, LLC, which owns a manufacturing company, for a purchase price of $21.0 million and a possible earnout of $1.0 million. The purchase price included $12.6 million in cash and $8.4 million in the Company's stock (169,560 shares based on the closing stock price of $49.54 per share on February 28, 2017). Dr. Dana Beauty, LLC In the third quarter of 2017, the Company acquired certain assets of Dr. Dana Beauty, LLC for $7 million in cash. The acquisition, which was accounted for as an asset acquisition, includes contingent consideration of $4.3 million. The assets acquired include trademarks, product formulas and other intellectual property primarily related to nail treatment.

THE COMPANY (Policies)

THE COMPANY (Policies)	9 Months Ended
THE COMPANY (Policies)	Sep. 30, 2017
THE COMPANY [Abstract]
Basis of Accounting	The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. The unaudited consolidated financial statements include the accounts of the Company and its Subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation. In the opinion of management, the accompanying unaudited consolidated financial statements contain all adjustments, consisting of normal recurring adjustments, considered necessary for a fair statement of the Company's financial information as of September 30, 2017, and for the three- and nine-month periods ended September 30, 2017 and 2016. The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the fiscal year. The consolidated balance sheet as of December 31, 2016 has been prepared using information from the audited financial statements at that date. For further information, refer to the consolidated financial statements and accompanying footnotes included in the Company's Annual Report on Form 10-K for the year ended December 31, 2016.

ACCOUNTING PRONOUNCEMENTS (Poli

ACCOUNTING PRONOUNCEMENTS (Policies)	9 Months Ended
ACCOUNTING PRONOUNCEMENTS (Policies)	Sep. 30, 2017
ACCOUNTING PRONOUNCEMENTS [Abstract]
Accounting Pronouncements	In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606) In July 2015, the FASB issued ASU 2015-11, Inventory (Topic 330): Simplifying the Measurement of Inventory In February 2016, the FASB issued ASU 2016-02, Leases (Subtopic 842) In March 2016, the FASB issued ASU 2016-09, Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting . The objective of this update was to simplify several aspects of the accounting for employee share-based payment transactions, including accounting for income taxes related to share-based compensation, the related classification in the statement of cash-flows, and accounting for share award forfeitures. This ASU was effective for the Company beginning on January 1, 2017 As permitted, the Company elected to classify excess tax benefits as an operating activity in the Statement of Cash Flows instead of as a financing activity on a prospective basis and did not retroactively adjust prior periods. As also permitted by the new guidance, beginning January 1, 2017 the Company has elected to account for share award forfeitures as they occur. Previously, share-based compensation expense was recorded net of estimated forfeitures. A cumulative adjustment of $2.8 million was recorded to retained earnings and additional paid-in capital as of January 1, 2017. Prior periods were not retroactively adjusted. In the second half of 2016, the FASB issued ASU Nos. 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments Statement of Cash Flows (Topic 230): Restricted Cash. In January 2017, the FASB issued ASU 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a In January 2017, the FASB issued ASU 2017-04, Intangibles – Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment . This guidance simplifies the required test of goodwill for impairment by eliminating Step 2 from the goodwill impairment test. If a company determines in Step 1 of the goodwill impairment test that the carrying value of goodwill is less than the fair value, an impairment in that amount should be recorded to the income statement, rather than proceeding to Step 2. This ASU is effective for interim and annual impairment tests in fiscal years beginning after December 15, 2019. Early adoption is permitted. The adoption of this guidance is not expected to have a material impact on the Company's consolidated financial statements. In December 2017, the FASB issued ASU No. 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities The

DERIVATIVE FINANCIAL INSTRUME26

DERIVATIVE FINANCIAL INSTRUMENTS (Tables)	9 Months Ended
DERIVATIVE FINANCIAL INSTRUMENTS (Tables)	Sep. 30, 2017
DERIVATIVE FINANCIAL INSTRUMENTS [Abstract]
Gains (Losses) Related to Derivative Instruments Not Designated as Hedging Instruments	The following table summarizes gains (losses) related to derivative instruments not designated as hedging instruments during the three- and nine-month periods ended September 30, 2017 and 2016 (U.S. dollars in thousands): Derivatives not designated as hedging instruments: Location of Gain (Loss) Recognized in Income Amount of Gain (Loss) Recognized in Income Three Months Ended Nine Months Ended September 30, September 30, 2017 2016 2017 2016 Foreign currency contracts Other income (expense) $ — $ (765) $ (485) $ (1,243)
Gains (Losses) Related to Derivative Instruments Designated as Cash Flow Hedges	The following table summarizes gains (losses) related to derivative instruments recorded in other comprehensive income (loss) during the three- and nine-month periods ended September 30, 2017 and 2016 (U.S. dollars in thousands): Amount of Gain (Loss) Recognized in Other Comprehensive Loss Three Months Ended Nine Months Ended September 30, September 30, Derivatives designated as hedging instruments: 2017 2016 2017 2016 Foreign currency forward contracts related to intercompany license fee, product sales, and selling expense hedges $ (27) $ (266) $ (207) $ (3,126) The following table summarizes gains (losses) relating to derivative instruments reclassified from accumulated other comprehensive loss into income during the three- and nine-month periods ended September 30, 2017 and 2016 (U.S. dollars in thousands): Derivatives designated as hedging instruments: Location of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income Three Months Ended Nine Months Ended September 30, September 30, 2017 2016 2017 2016 Foreign currency forward contracts related to intercompany license fees and product sales hedges Revenue $ (67) $ (300) $ 42 $ (609) Foreign currency forward contracts related to intercompany selling expense hedges Selling expenses $ 5 $ (443) $ 233 $ (850)

SEGMENT INFORMATION (Tables)

SEGMENT INFORMATION (Tables)	9 Months Ended
SEGMENT INFORMATION (Tables)	Sep. 30, 2017
SEGMENT INFORMATION [Abstract]
Revenue by Segment	Revenue by Segment Three Months Ended September 30, Nine Months Ended September 30, (U.S. dollars in thousands) 2017 2016 2017 2016 Mainland China $ 172,556 $ 168,320 $ 494,658 $ 471,319 South Korea 89,238 136,188 258,626 315,342 Americas 79,214 71,250 221,968 204,882 South Asia/Pacific 78,994 70,867 216,727 226,742 Japan 62,513 72,489 188,465 210,429 Hong Kong/Taiwan 41,050 48,140 120,069 140,568 EMEA 40,133 36,908 112,385 107,186 Total $ 563,698 $ 604,162 $ 1,612,898 $ 1,676,468
Segment Contribution	Segment Contribution Three Months Ended September 30, Nine Months Ended September 30, (U.S. dollars in thousands) 2017 2016 2017 2016 Mainland China $ 42,375 $ 38,240 $ 130,085 $ 113,250 South Korea 23,713 41,739 70,503 89,991 Americas 12,822 11,637 34,564 34,286 South Asia/Pacific 18,664 16,371 47,083 53,172 Japan 12,786 15,510 36,134 43,490 Hong Kong/Taiwan 8,096 10,401 20,945 25,829 EMEA 2,896 3,258 8,304 6,438 Total segment contribution 121,352 137,156 347,618 366,456 Corporate and other (56,990 ) (54,782 ) (172,255 ) (196,135 ) Operating income 64,362 82,374 175,363 170,321 Other income (expense) (1,172 ) (5,695 ) (8,470 ) (19,618 ) Income before provision for income taxes $ 63,190 $ 76,679 $ 166,893 $ 150,703
Depreciation and Amortization and Capital Expenditures	Depreciation and Amortization Three Months Ended September 30, Nine Months Ended September 30, (U.S. dollars in thousands) 2017 2016 2017 2016 Mainland China $ 3,550 $ 4,218 $ 11,202 $ 12,362 South Korea 1,586 1,773 4,872 5,137 Americas 341 672 1,319 2,010 South Asia/Pacific 585 636 1,733 1,796 Japan 898 1,002 2,677 2,848 Hong Kong/Taiwan 353 558 999 1,669 EMEA 226 356 820 1,027 Corporate and other 9,906 9,503 28,903 26,553 Total $ 17,445 $ 18,718 $ 52,525 $ 53,402 Capital Expenditures Three Months Ended September 30, Nine Months Ended September 30, (U.S. dollars in thousands) 2017 2016 2017 2016 Mainland China $ 688 $ 1,711 $ 2,351 $ 8,709 South Korea — 141 464 520 Americas 133 96 697 585 South Asia/Pacific 284 235 814 1,978 Japan 109 49 206 916 Hong Kong/Taiwan 2 179 1,119 444 EMEA 571 131 882 798 Corporate and other 9,427 7,763 32,432 21,069 Total $ 11,214 $ 10,305 $ 38,965 $ 35,019
Revenue by Product Line	Revenue by Product Line Three Months Ended Nine Months Ended September 30, September 30, 2017 2016 2017 2016 Nu Skin $ 338,305 $ 343,131 $ 985,465 $ 998,386 Pharmanex 224,031 259,896 623,046 674,624 Other 1,362 1,135 4,387 3,458 Totals $ 563,698 $ 604,162 $ 1,612,898 $ 1,676,468
Long-lived Assets by Major Markets	Long-lived assets by major markets are set forth below for the periods ended September 30, 2017 and December 31, 2016 (U.S. dollars in thousands): September 30, 2017 December 31, 2016 United States $ 294,567 $ 283,868 Mainland China 93,108 97,867 South Korea 40,446 41,545 Japan 9,447 11,517 All others 11,987 9,935 Total $ 449,555 $ 444,732

GOODWILL (Tables)

GOODWILL (Tables)	9 Months Ended
GOODWILL (Tables)	Sep. 30, 2017
GOODWILL [Abstract]
Goodwill	The following table presents goodwill allocated to the Company's reportable segments for the periods ended September 30, 2017 and December 31, 2016 (U.S. dollars in thousands): September 30, 2017 December 31, 2016 (1) Mainland China $ 32,179 $ 32,179 South Korea 29,261 29,261 Americas 9,449 9,449 South Asia/Pacific 18,537 18,537 Japan 16,019 16,019 Hong Kong/Taiwan 6,634 6,634 EMEA 2,875 2,875 Total $ 114,954 $ 114,954 (1) Goodwill was recast to reflect current period presentation by geographic region at December 31, 2016.

INVENTORY (Tables)

INVENTORY (Tables)	9 Months Ended
INVENTORY (Tables)	Sep. 30, 2017
INVENTORY [Abstract]
Inventories	Inventories consist of the following (U.S. dollars in thousands): September 30, 2017 December 31, 2016 Raw materials $ 95,339 $ 108,276 Finished goods 157,131 141,660 $ 252,470 $ 249,936

DEBT (Tables)

DEBT (Tables)	9 Months Ended
DEBT (Tables)	Sep. 30, 2017
DEBT [Abstract]
Convertible Note	The net carrying amount of the Liability Component is as follows (U.S. dollars in thousands): September 30, 2017 Principal $ 210,000 Unamortized debt discount (conversion option) (7,731 ) Total long-term debt, net 202,269 Unamortized debt discount (issuance costs) (4,424 ) Net carrying amount $ 197,845
Debt Facilities	The following table summarizes the Company’s debt facilities as of September 30, 2017 and December 31, 2016: Facility or Arrangement Original Principal Amount Balance as of September 30, 2017 (1)(2) Balance as of December 31, 2016 Interest Rate Repayment terms Credit Agreement term loan facility: U.S. dollar denominated: $127.5 million $98.8 million $108.4 million Variable 30 day: 3.98% One half of the principal amount payable in increasing quarterly installments over a five-year period beginning on December 31, 2014, with the remainder payable at the end of the five-year term. Japanese yen denominated: 6.6 billion yen 5.1 billion yen ($45.4 million as of September 30, 2017) 5.6 billion yen ($47.9 million as of December 31, 2016) Variable 30 day: 2.75% One half of the principal amount payable in increasing quarterly installments over a five-year period beginning on December 31, 2014, with the remainder payable at the end of the five-year term. Credit Agreement revolving credit facility: $72.5 million $47.5 million Variable 30 day: 3.98% Revolving line of credit expires October 2019. Korea subsidiary loan: $20.0 million — $10.0 million 1.12% Loan paid in full as of March 2017. Japan subsidiary loan: 2.0 billion yen 0.7 billion yen ($5.9 million as of September 30, 2017) 1.3 billion yen ($11.4 million as of December 31, 2016) 0.66% Payable in semi-annual installments over three years that began on January 31, 2016. Convertible note: $210.0 million $210.0 million $210.0 million 4.75% Principal amount payable on June 15, 2020. (1) As of September 30, 2017, the current portion of the Company's debt (i.e. becoming due in the next 12 months) included $16.0 million of the balance of its U.S. dollar denominated debt under the Credit Agreement facility, $7.3 million of the balance of its Japanese yen-denominated debt under the Credit Agreement facility and $5.9 million of the Japan subsidiary loan. The Company has classified the $72.5 million borrowed under the revolving line of credit as short term because it is the Company's intention to use the line of credit to borrow and pay back funds over short periods of time. (2) The carrying value of the debt reflects the amounts stated in the above table less a debt discount of $10.0 million and debt issuance costs of $4.4 million (consisting of $12.1 million related to the Convertible Note and $2.3 million related to the credit agreement), which is not reflected in this table.

FAIR VALUE (Tables)

FAIR VALUE (Tables)	9 Months Ended
FAIR VALUE (Tables)	Sep. 30, 2017
FAIR VALUE [Abstract]
Assets and Liabilities Measured at Fair Value on a Recurring Basis	The following tables present the fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis (U.S. dollars in thousands): Fair Value at September 30, 2017 Level 1 Level 2 Level 3 Total Financial assets (liabilities): Cash equivalents and current investments $ 40,070 $ — $ — $ 40,070 Other long-term assets 3,472 — — 3,472 Forward contracts — 275 — 275 Life insurance contracts — — 36,747 36,747 Total $ 43,542 $ 275 $ 36,747 $ 80,564 Fair Value at December 31, 2016 Level 1 Level 2 Level 3 Total Financial assets (liabilities): Cash equivalents and current investments $ 50,307 $ — $ — $ 50,307 Other long-term assets 2,782 — — 2,782 Forward contracts — 1,371 — 1,371 Life insurance contracts — — 32,286 32,286 Total $ 53,089 $ 1,371 $ 32,286 $ 86,746
Changes in Fair Value of Level 3 Marketable Securities	The following table provides a summary of changes in fair value of the Company's Level 3 marketable securities (U.S. dollars in thousands): Life Insurance Contracts Beginning balance at January 1, 2017 $ 32,286 Actual return on plan assets: Relating to assets still held at the reporting date 3,835 Purchases and issuances 895 Sales and settlements (269 ) Transfers into Level 3 — Ending balance at September 30, 2017 $ 36,747

THE COMPANY (Details)

THE COMPANY (Details)	9 Months Ended
THE COMPANY (Details)	Sep. 30, 2017Segment
THE COMPANY [Abstract]
Number of segments	7

NET INCOME PER SHARE (Details)

NET INCOME PER SHARE (Details) - shares shares in Millions	3 Months Ended		9 Months Ended
NET INCOME PER SHARE (Details) - shares shares in Millions	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Stock Options [Member]
Net Income per Share [Abstract]
Anti-dilutive shares excluded from calculation of diluted earnings per share (in shares)	0.2	0.2	0.4	1.2

DIVIDENDS PER SHARE (Details)

DIVIDENDS PER SHARE (Details) - USD ($) $ / shares in Units, $ in Thousands	Sep. 13, 2017	Jun. 14, 2017	Mar. 15, 2017	Oct. 31, 2017	Aug. 31, 2017	May 31, 2017	Feb. 28, 2017	Sep. 30, 2017	Sep. 30, 2016
Dividends per Share [Abstract]
Payment of cash dividends								$ 57,065	$ 59,585
Dividend Declared 2017-Q1 [Member]
Dividends per Share [Abstract]
Dividend payable, date declared								2017-02
Dividend payable per share (in dollars per share)							$ 0.36
Payment of cash dividends			$ 19,000
Dividend payable, date to be paid								Mar. 15, 2017
Dividend payable, date of record								Feb. 27, 2017
Dividend Declared 2017-Q2 [Member]
Dividends per Share [Abstract]
Dividend payable, date declared								2017-05
Dividend payable per share (in dollars per share)						$ 0.36
Payment of cash dividends		$ 19,100
Dividend payable, date to be paid								Jun. 14, 2017
Dividend payable, date of record								May 26, 2017
Dividend Declared 2017-Q3 [Member]
Dividends per Share [Abstract]
Dividend payable, date declared								2017-08
Dividend payable per share (in dollars per share)					$ 0.36
Payment of cash dividends	$ 19,000
Dividend payable, date to be paid								Sep. 13, 2017
Dividend payable, date of record								Aug. 25, 2017
Dividend Declared 2017-Q4 [Member] \| Subsequent Event [Member]
Dividends per Share [Abstract]
Dividend payable, date declared				2017-10
Dividend payable per share (in dollars per share)				$ 0.36
Dividend payable, date to be paid				Dec. 6, 2017
Dividend payable, date of record				Nov. 17, 2017

DERIVATIVE FINANCIAL INSTRUME35

DERIVATIVE FINANCIAL INSTRUMENTS (Details) $ in Thousands, € in Millions, ¥ in Millions, ₩ in Billions	3 Months Ended		9 Months Ended
	Sep. 30, 2017USD ($)	Sep. 30, 2016USD ($)	Sep. 30, 2017USD ($)	Sep. 30, 2016USD ($)	Sep. 30, 2017JPY (¥)	Dec. 31, 2016USD ($)	Sep. 30, 2016KRW (₩)	Sep. 30, 2016EUR (€)	Sep. 30, 2016JPY (¥)
Foreign Currency Derivatives [Abstract]
Unrealized gains/(losses) related to foreign currency cash flow hedges included in accumulated other comprehensive loss	$ 200		$ 200			$ 600
Cumulative translation adjustments included in accumulated other comprehensive loss	69,400		69,400			$ 84,700
Foreign Currency Forward Contracts [Member] \| Not Designated as Hedging Instrument [Member] \| Fair Value Hedges [Member] \| Japanese Yen [Member]
Foreign Currency Derivatives [Abstract]
Notional amount		$ 3,000		$ 3,000					¥ 300
Foreign Currency Forward Contracts [Member] \| Not Designated as Hedging Instrument [Member] \| Fair Value Hedges [Member] \| Korean Won [Member]
Foreign Currency Derivatives [Abstract]
Notional amount		10,400		10,400			₩ 11.5
Foreign Currency Forward Contracts [Member] \| Designated as Hedging Instrument [Member] \| Cash Flow Hedges [Member]
Foreign Currency Derivatives [Abstract]
Fair value	300	(2,100)	$ 300	(2,100)
Term to recognize gains (losses) in current earnings			9 months
Foreign Currency Forward Contracts [Member] \| Designated as Hedging Instrument [Member] \| Cash Flow Hedges [Member] \| Japanese Yen [Member]
Foreign Currency Derivatives [Abstract]
Notional amount	12,400	22,700	$ 12,400	22,700	¥ 1,400				¥ 2,300
Foreign Currency Forward Contracts [Member] \| Designated as Hedging Instrument [Member] \| Cash Flow Hedges [Member] \| Euros [Member]
Foreign Currency Derivatives [Abstract]
Notional amount		6,700		6,700				€ 6
Foreign Currency Forward Contracts [Member] \| Other Comprehensive Loss [Member] \| Designated as Hedging Instrument [Member] \| Cash Flow Hedges [Member]
Foreign Currency Derivatives [Abstract]
Gain (loss) recognized in other comprehensive income loss	(27)	(266)	(207)	(3,126)
Foreign Currency Forward Contracts [Member] \| Other Income (Expense) [Member] \| Not Designated as Hedging Instrument [Member] \| Fair Value Hedges [Member]
Foreign Currency Derivatives [Abstract]
Gain (loss) recognized in income	0	(765)	(485)	(1,243)
Foreign Currency Forward Contracts [Member] \| Revenue [Member] \| Designated as Hedging Instrument [Member] \| Cash Flow Hedges [Member]
Foreign Currency Derivatives [Abstract]
Gain (loss) reclassified from accumulated other comprehensive loss into income	(67)	(300)	42	(609)
Foreign Currency Forward Contracts [Member] \| Selling Expenses [Member] \| Designated as Hedging Instrument [Member] \| Cash Flow Hedges [Member]
Foreign Currency Derivatives [Abstract]
Gain (loss) reclassified from accumulated other comprehensive loss into income	$ 5	$ (443)	$ 233	$ (850)

REPURCHASES OF COMMON STOCK (De

REPURCHASES OF COMMON STOCK (Details) - Common Class A [Member] - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Repurchases of Common Stock [Abstract]
Common stock repurchased (in shares)	0.4	0.3	0.8	1
Common stock repurchased	$ 25.7	$ 17.4	$ 47.8	$ 41.7
Available for repurchase under the repurchase program	$ 151.9		$ 151.9

SEGMENT INFORMATION, Revenue by

SEGMENT INFORMATION, Revenue by Segment (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017USD ($)	Sep. 30, 2016USD ($)	Sep. 30, 2017USD ($)SegmentMarket	Sep. 30, 2016USD ($)
SEGMENT INFORMATION [Abstract]
Number of markets \| Market			50
Number of segments \| Segment			7
Revenue by Segment [Abstract]
Revenue	$ 563,698	$ 604,162	$ 1,612,898	$ 1,676,468
Operating Segment [Member]
Revenue by Segment [Abstract]
Revenue	563,698	604,162	1,612,898	1,676,468
Operating Segment [Member] \| Mainland China [Member]
Revenue by Segment [Abstract]
Revenue	172,556	168,320	494,658	471,319
Operating Segment [Member] \| South Korea [Member]
Revenue by Segment [Abstract]
Revenue	89,238	136,188	258,626	315,342
Operating Segment [Member] \| Americas [Member]
Revenue by Segment [Abstract]
Revenue	79,214	71,250	221,968	204,882
Operating Segment [Member] \| South Asia/Pacific [Member]
Revenue by Segment [Abstract]
Revenue	78,994	70,867	216,727	226,742
Operating Segment [Member] \| Japan [Member]
Revenue by Segment [Abstract]
Revenue	62,513	72,489	188,465	210,429
Operating Segment [Member] \| Hong Kong/Taiwan [Member]
Revenue by Segment [Abstract]
Revenue	41,050	48,140	120,069	140,568
Operating Segment [Member] \| EMEA [Member]
Revenue by Segment [Abstract]
Revenue	$ 40,133	$ 36,908	$ 112,385	$ 107,186

SEGMENT INFORMATION, Segment Co

SEGMENT INFORMATION, Segment Contribution (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Segment Contribution [Abstract]
Operating income	$ 64,362	$ 82,374	$ 175,363	$ 170,321
Other income (expense)	(1,172)	(5,695)	(8,470)	(19,618)
Income before provision for income taxes	63,190	76,679	166,893	150,703
Operating Segment [Member]
Segment Contribution [Abstract]
Operating income	121,352	137,156	347,618	366,456
Operating Segment [Member] \| Mainland China [Member]
Segment Contribution [Abstract]
Operating income	42,375	38,240	130,085	113,250
Operating Segment [Member] \| South Korea [Member]
Segment Contribution [Abstract]
Operating income	23,713	41,739	70,503	89,991
Operating Segment [Member] \| Americas [Member]
Segment Contribution [Abstract]
Operating income	12,822	11,637	34,564	34,286
Operating Segment [Member] \| South Asia/Pacific [Member]
Segment Contribution [Abstract]
Operating income	18,664	16,371	47,083	53,172
Operating Segment [Member] \| Japan [Member]
Segment Contribution [Abstract]
Operating income	12,786	15,510	36,134	43,490
Operating Segment [Member] \| Hong Kong/Taiwan [Member]
Segment Contribution [Abstract]
Operating income	8,096	10,401	20,945	25,829
Operating Segment [Member] \| EMEA [Member]
Segment Contribution [Abstract]
Operating income	2,896	3,258	8,304	6,438
Corporate and Other [Member]
Segment Contribution [Abstract]
Operating income	$ (56,990)	$ (54,782)	$ (172,255)	$ (196,135)

SEGMENT INFORMATION, Depreciati

SEGMENT INFORMATION, Depreciation and Amortization and Capital Expenditures (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Summarized Financial Information [Abstract]
Depreciation and amortization	$ 17,445	$ 18,718	$ 52,525	$ 53,402
Capital expenditures	11,214	10,305	38,965	35,019
Reportable Geographic Region [Member] \| Mainland China [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	3,550	4,218	11,202	12,362
Capital expenditures	688	1,711	2,351	8,709
Reportable Geographic Region [Member] \| South Korea [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	1,586	1,773	4,872	5,137
Capital expenditures	0	141	464	520
Reportable Geographic Region [Member] \| Americas [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	341	672	1,319	2,010
Capital expenditures	133	96	697	585
Reportable Geographic Region [Member] \| South Asia/Pacific [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	585	636	1,733	1,796
Capital expenditures	284	235	814	1,978
Reportable Geographic Region [Member] \| Japan [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	898	1,002	2,677	2,848
Capital expenditures	109	49	206	916
Reportable Geographic Region [Member] \| Hong Kong/Taiwan [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	353	558	999	1,669
Capital expenditures	2	179	1,119	444
Reportable Geographic Region [Member] \| EMEA [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	226	356	820	1,027
Capital expenditures	571	131	882	798
Corporate and Other [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	9,906	9,503	28,903	26,553
Capital expenditures	$ 9,427	$ 7,763	$ 32,432	$ 21,069

SEGMENT INFORMATION, Revenue 40

SEGMENT INFORMATION, Revenue by Major Market (Details)	9 Months Ended
SEGMENT INFORMATION, Revenue by Major Market (Details)	Sep. 30, 2017Market
SEGMENT INFORMATION [Abstract]
Number of major markets	3
Number of markets	50

SEGMENT INFORMATION, Revenue 41

SEGMENT INFORMATION, Revenue by Product Line (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Revenue by Product Line [Abstract]
Revenue	$ 563,698	$ 604,162	$ 1,612,898	$ 1,676,468
Nu Skin [Member]
Revenue by Product Line [Abstract]
Revenue	338,305	343,131	985,465	998,386
Pharmanex [Member]
Revenue by Product Line [Abstract]
Revenue	224,031	259,896	623,046	674,624
Other [Member]
Revenue by Product Line [Abstract]
Revenue	$ 1,362	$ 1,135	$ 4,387	$ 3,458

SEGMENT INFORMATION, Long-Lived

SEGMENT INFORMATION, Long-Lived Assets by Major Market (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Long-Lived Assets by Major Market [Abstract]
Long-lived assets	$ 449,555	$ 444,732
Major Markets [Member] \| United States [Member]
Long-Lived Assets by Major Market [Abstract]
Long-lived assets	294,567	283,868
Major Markets [Member] \| Mainland China [Member]
Long-Lived Assets by Major Market [Abstract]
Long-lived assets	93,108	97,867
Major Markets [Member] \| South Korea [Member]
Long-Lived Assets by Major Market [Abstract]
Long-lived assets	40,446	41,545
Major Markets [Member] \| Japan [Member]
Long-Lived Assets by Major Market [Abstract]
Long-lived assets	9,447	11,517
Major Markets [Member] \| All Other Countries [Member]
Long-Lived Assets by Major Market [Abstract]
Long-lived assets	$ 11,987	$ 9,935

GOODWILL (Details)

GOODWILL (Details) $ in Thousands	9 Months Ended
GOODWILL (Details) $ in Thousands	Sep. 30, 2017USD ($)Segment	Dec. 31, 2016USD ($)
Goodwill [Abstract]
Number of segments \| Segment	7
Goodwill	$ 114,954	$ 114,954
Mainland China [Member]
Goodwill [Abstract]
Goodwill	32,179	32,179	[1]
South Korea [Member]
Goodwill [Abstract]
Goodwill	29,261	29,261	[1]
Americas [Member]
Goodwill [Abstract]
Goodwill	9,449	9,449	[1]
South Asia/Pacific [Member]
Goodwill [Abstract]
Goodwill	18,537	18,537	[1]
Japan [Member]
Goodwill [Abstract]
Goodwill	16,019	16,019	[1]
Hong Kong/Taiwan [Member]
Goodwill [Abstract]
Goodwill	6,634	6,634	[1]
EMEA [Member]
Goodwill [Abstract]
Goodwill	$ 2,875	$ 2,875	[1]

[1]	Goodwill was recast to reflect current period presentation by geographic region at December 31, 2016.

INVENTORY (Details)

INVENTORY (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Inventories [Abstract]
Raw materials	$ 95,339	$ 108,276
Finished goods	157,131	141,660
Inventories	$ 252,470	$ 249,936

DEFERRED TAX ASSETS AND LIABI45

DEFERRED TAX ASSETS AND LIABILITIES (Details) - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016
DEFERRED TAX ASSETS AND LIABILITIES [Abstract]
Net deferred tax assets	$ 29.3	$ 35.1
Undistributed foreign earnings indefinitely reinvested		70
Incremental taxes on indefinitely reinvested foreign earnings		$ 7.6

UNCERTAIN TAX POSITIONS (Detail

UNCERTAIN TAX POSITIONS (Details)	9 Months Ended
UNCERTAIN TAX POSITIONS (Details)	Sep. 30, 2017
UNCERTAIN TAX POSITIONS [Abstract]
Statute period for transfer pricing related issues	10 years

DEBT, Credit Agreement (Details

DEBT, Credit Agreement (Details) $ in Millions, ¥ in Billions	9 Months Ended
	Sep. 30, 2017USD ($)		Sep. 30, 2017JPY (¥)		Dec. 31, 2016USD ($)	Dec. 31, 2016JPY (¥)	Oct. 09, 2014USD ($)	Oct. 09, 2014JPY (¥)
Credit Agreement [Member] \| Maximum [Member]
Debt [Abstract]
Consolidated leverage ratio	2.25
Credit Agreement [Member] \| Minimum [Member]
Debt [Abstract]
Consolidated interest coverage ratio	3
Term Loan Facility [Member]
Debt [Abstract]
Original principal amount	$ 127.5						$ 127.5
Term of facility	5 years
Outstanding balance	$ 98.8	[1],[2]			$ 108.4
Japanese Yen Term Loan Facility [Member]
Debt [Abstract]
Original principal amount \| ¥			¥ 6.6					¥ 6.6
Term of facility	5 years
Outstanding balance	$ 45.4	[1],[2]	¥ 5.1	[1],[2]	47.9	¥ 5.6
Revolving Credit Facility [Member]
Debt [Abstract]
Borrowing capacity							$ 187.5
Term of facility	5 years
Outstanding balance	$ 72.5	[1],[2]			$ 47.5

[1]	As of September 30, 2017, the current portion of the Company's debt (i.e. becoming due in the next 12 months) included $16.0 million of the balance of its U.S. dollar denominated debt under the Credit Agreement facility, $7.3 million of the balance of its Japanese yen-denominated debt under the Credit Agreement facility and $5.9 million of the Japan subsidiary loan. The Company has classified the $72.5 million borrowed under the revolving line of credit as short term because it is the Company's intention to use the line of credit to borrow and pay back funds over short periods of time.
[2]	The carrying value of the debt reflects the amounts stated in the above table less a debt discount of $10.0 million and debt issuance costs of $4.4 million (consisting of $12.1 million related to the Convertible Note and $2.3 million related to the credit agreement), which is not reflected in this table.

Debt, Convertible Note (Details

Debt, Convertible Note (Details)	Jun. 16, 2016USD ($)	Sep. 30, 2017USD ($)$ / shares	Sep. 30, 2017USD ($)d$ / sharesshares	Sep. 30, 2016USD ($)	Dec. 31, 2016USD ($)
Net Carrying Amount of Liability Component [Abstract]
Unamortized debt discount (conversion option)		$ (10,000,000)	$ (10,000,000)
Unamortized debt discount (issuance costs)		(4,400,000)	(4,400,000)
Debt issuance costs			0	$ 6,596,000
Convertible Note [Member]
Convertible Debt [Abstract]
Original principal amount	$ 210,000,000	$ 210,000,000	$ 210,000,000
Interest rate		4.75%	4.75%
Maturity date			Jun. 15, 2020
Redemption price, percentage of principal amount redeemed			100.00%
Threshold percentage of stock price trigger			180.00%
Threshold trading days \| d			20
Threshold final trading days \| d			3
Threshold consecutive trading days \| d			30
Principal amount increments that can be repurchased upon a change in control or termination of trading of common stock			$ 1,000
Principal amount increments that can be converted			$ 1,000
Holding period following issue date before notes can be converted			6 months
Initial conversion rate (in shares) \| shares			21.5054
Initial conversion price (in dollars per share) \| $ / shares		$ 46.50	$ 46.50
Proceeds from issuance of notes	210,000,000
Liability component of convertible notes	199,100,000
Equity component of convertible notes allocated to additional paid-in capital	$ 10,900,000
Effective interest rate		7.10%	7.10%
Net Carrying Amount of Liability Component [Abstract]
Principal		$ 210,000,000	$ 210,000,000		$ 210,000,000
Unamortized debt discount (conversion option)		(7,731,000)	(7,731,000)
Total long-term debt, net		202,269,000	202,269,000
Unamortized debt discount (issuance costs)		(4,424,000)	(4,424,000)
Net carrying amount		197,845,000	197,845,000
Debt issuance costs			6,600,000
Additions to deferred financing cost			6,300,000
Adjustments to additional paid-in capital for debt issuance costs			$ 300,000
Interest expense		3,500,000
Contractual interest		2,500,000
Amortization of debt issuance costs and debt discount		$ 1,000,000

Debt, Debt Facilities (Details)

Debt, Debt Facilities (Details) $ in Thousands, ¥ in Billions	9 Months Ended
	Sep. 30, 2017USD ($)		Sep. 30, 2017JPY (¥)		Dec. 31, 2016USD ($)	Dec. 31, 2016JPY (¥)	Jun. 16, 2016USD ($)	Oct. 09, 2014USD ($)	Oct. 09, 2014JPY (¥)
Debt [Abstract]
Current portion of debt	$ 101,701				$ 82,727
Unamortized debt discount	10,000
Unamortized debt issuance costs	4,400
Credit Agreement [Member]
Debt [Abstract]
Unamortized debt discount and debt issuance costs	2,300
Term Loan Facility [Member]
Debt [Abstract]
Original principal amount	127,500							$ 127,500
Balance	$ 98,800	[1],[2]			108,400
Interest rate	Variable 30 day: 3.98%
Interest rate	3.98%		3.98%
Term of variable rate	30 days
Repayment terms	One half of the principal amount payable in increasing quarterly installments over a five-year period beginning on December 31, 2014, with the remainder payable at the end of the five-year term.
Percentage of principal payable in installments	50.00%
Frequency of payment	Quarterly
Term of loan	5 years
Current portion of debt	$ 16,000
Japanese Yen Term Loan Facility [Member]
Debt [Abstract]
Original principal amount \| ¥			¥ 6.6						¥ 6.6
Balance	$ 45,400	[1],[2]	¥ 5.1	[1],[2]	47,900	¥ 5.6
Interest rate	Variable 30 day: 2.75%
Interest rate	2.75%		2.75%
Term of variable rate	30 days
Repayment terms	One half of the principal amount payable in increasing quarterly installments over a five-year period beginning on December 31, 2014, with the remainder payable at the end of the five-year term.
Percentage of principal payable in installments	50.00%
Frequency of payment	Quarterly
Term of loan	5 years
Current portion of debt	$ 7,300
Revolving Credit Facility [Member]
Debt [Abstract]
Balance	$ 72,500	[1],[2]			47,500
Interest rate	Variable 30 day: 3.98%
Interest rate	3.98%		3.98%
Term of variable rate	30 days
Repayment terms	Revolving line of credit expires October 2019.
Term of loan	5 years
Korean Subsidiary Loan [Member]
Debt [Abstract]
Original principal amount	$ 20,000
Balance	$ 0	[1],[2]			10,000
Interest rate	1.12%		1.12%
Repayment terms	Loan paid in full as of March 2017.
Japan Subsidiary Loan [Member]
Debt [Abstract]
Original principal amount \| ¥			¥ 2
Balance	$ 5,900	[1],[2]	¥ 0.7	[1],[2]	11,400	¥ 1.3
Interest rate	0.66%		0.66%
Repayment terms	Payable in semi-annual installments over three years that began on January 31, 2016.
Frequency of payment	Semi-annual
Term of loan	3 years
Current portion of debt	$ 5,900
Convertible Note [Member]
Debt [Abstract]
Original principal amount	210,000						$ 210,000
Balance	$ 210,000				$ 210,000
Interest rate	7.10%		7.10%
Interest rate	4.75%		4.75%
Repayment terms	Principal amount payable on June 15, 2020.
Unamortized debt discount	$ 7,731
Unamortized debt issuance costs	4,424
Unamortized debt discount and debt issuance costs	$ 12,100

[1]	As of September 30, 2017, the current portion of the Company's debt (i.e. becoming due in the next 12 months) included $16.0 million of the balance of its U.S. dollar denominated debt under the Credit Agreement facility, $7.3 million of the balance of its Japanese yen-denominated debt under the Credit Agreement facility and $5.9 million of the Japan subsidiary loan. The Company has classified the $72.5 million borrowed under the revolving line of credit as short term because it is the Company's intention to use the line of credit to borrow and pay back funds over short periods of time.
[2]	The carrying value of the debt reflects the amounts stated in the above table less a debt discount of $10.0 million and debt issuance costs of $4.4 million (consisting of $12.1 million related to the Convertible Note and $2.3 million related to the credit agreement), which is not reflected in this table.

FAIR VALUE (Details)

FAIR VALUE (Details) - USD ($) $ in Thousands	9 Months Ended
FAIR VALUE (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Fair Value on a Recurring Basis [Member]
Financial Assets (Liabilities) [Abstract]
Cash equivalents and current investments	$ 40,070	$ 50,307
Other long-term assets	3,472	2,782
Forward contracts	275	1,371
Life insurance contracts	36,747	32,286
Financial assets (liabilities), net	80,564	86,746
Fair Value on a Recurring Basis [Member] \| Level 1 [Member]
Financial Assets (Liabilities) [Abstract]
Cash equivalents and current investments	40,070	50,307
Other long-term assets	3,472	2,782
Forward contracts	0	0
Life insurance contracts	0	0
Financial assets (liabilities), net	43,542	53,089
Fair Value on a Recurring Basis [Member] \| Level 2 [Member]
Financial Assets (Liabilities) [Abstract]
Cash equivalents and current investments	0	0
Other long-term assets	0	0
Forward contracts	275	1,371
Life insurance contracts	0	0
Financial assets (liabilities), net	275	1,371
Fair Value on a Recurring Basis [Member] \| Level 3 [Member]
Financial Assets (Liabilities) [Abstract]
Cash equivalents and current investments	0	0
Other long-term assets	0	0
Forward contracts	0	0
Life insurance contracts	36,747	32,286
Financial assets (liabilities), net	36,747	$ 32,286
Life Insurance Contracts [Member]
Changes in Fair Value of Level 3 Marketable Securities [Roll Forward]
Beginning balance	32,286
Actual Return on Plan Assets [Abstract]
Relating to assets still held at the reporting date	3,835
Purchases and issuances	895
Sales and settlements	(269)
Transfers into Level 3	0
Ending balance	$ 36,747

ACCOUNTING PRONOUNCEMENTS (Deta

ACCOUNTING PRONOUNCEMENTS (Details) - Accounting Standards Update 2016-09 [Member] - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2017	Dec. 31, 2016
Accounting Pronouncements [Abstract]
Excess tax benefits	$ (1)	$ (4)
Retained Earnings [Member]
Accounting Pronouncements [Abstract]
Cumulative adjustment			$ (2.8)
Additional Paid-in Capital [Member]
Accounting Pronouncements [Abstract]
Cumulative adjustment			$ 2.8

COST OF SALES (Details)

COST OF SALES (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
COST OF SALES (Details) - USD ($) $ in Thousands	Mar. 31, 2016	Sep. 30, 2017	Sep. 30, 2016
COST OF SALES [Abstract]
Customs expense	$ 31,400	$ 0	$ 31,355

ACQUISITION AND INVESTMENT IN53

ACQUISITION AND INVESTMENT IN EQUITY INVESTEE (Details) - USD ($) $ / shares in Units, $ in Thousands	Feb. 28, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Acquisition [Abstract]
Cash paid for acquisition					$ 31,745	$ 4,400
Goodwill		$ 114,954			$ 114,954		$ 114,954
Vertical Eden, LLC [Member]
Acquisition [Abstract]
Percentage of entity acquired			30.00%	70.00%
Cash paid for acquisition			$ 12,500	$ 3,300
Contingent consideration				1,500
Goodwill				$ 2,500
Intangible assets			$ 4,400
Vertical Eden, LLC [Member] \| Minimum [Member]
Acquisition [Abstract]
Useful life					3 years
Vertical Eden, LLC [Member] \| Maximum [Member]
Acquisition [Abstract]
Useful life					7 years
Treviso, LLC [Member]
Acquisition [Abstract]
Percentage of entity acquired	35.00%
Purchase price	$ 21,000
Possible earnout	1,000
Investment in equity investee	12,600
Value of shares issued	$ 8,400
Number of shares issued (in shares)	169,560
Share price (in dollars per share)	$ 49.54
Dr. Dana Beauty, LLC [Member]
Acquisition [Abstract]
Cash paid for acquisition		7,000
Contingent consideration		$ 4,300